Uveitis Treatment Market 2022: Size, Share, Drivers, Restraints, Analysis and Forecast-2027
Uveitis is an inflammation that occurs in the uvea. It is found in
people aged between 20 to 50. Based on the origin of inflammation, uveitis
categories in major three types, namely, anterior uveitis, posterior uveitis,
and intermediate uveitis.
Uveitis
Treatment Market is expected to reach USD 764.5
Million at a CAGR of 5.6% during the forecast period.
Uveitis is an eye conditions, an inflammation of the middle layer of the
eyeball, called the uvea. Uveitis is manifested through symptoms such as
redness of the eye, pain, and blurred vision. These are the prime symptoms of
uveitis. The disease usually occurs in people aged 20 to 50 and can cause
significant distress due to the pain and blurry vision caused by the problem.
The growing prevalence of uveitis is the major driver for the global uveitis
treatment market over the forecast period from 2019 to 2025. The growing
prevalence of uveitis is due to the increasing threat of air pollution, which
is a major causative factor for the inflammation of delicate body parts such as
the inner regions of the eye. This is likely to remain a major driver for the
uveitis treatment market over the forecast period, as growing urbanization
around the world is likely to intensify the problem of air pollution in the
coming years.
Increasing expenditure on R&D to find solutions for uveitis is
likely to be a major driver for the global uveitis treatment market. The
increasing awareness about uveitis among the general populace is the key driver
for this phenomenon, as this has driven the demand for effective cures for the
condition. Increasing product launches in the uveitis treatment market are also
likely to remain a major driver for the market over the forecast period. On the
other hand, the widespread use of corticosteroid drugs is likely to be the
major restraint on the market, as there are various side effects of corticosteroid
drugs that patients want to avoid.
Major Key
Players:
Some of the key players in the Global Uveitis
Treatment Market Players are Allergan PLC,
Novartis AG, Bausch Health, EyePoint Pharmaceuticals, Inc., AbbVie Inc.,
Horizon Therapeutics PLC, Mylan N.V., and Alimera Sciences.
Segment Analysis
The global uveitis treatment market has been
segmented based on type, drug class, and end-user.
The market, based on type, has been divided into
anterior uveitis, intermediate uveitis, , posterior uveitis treatment and
others. The anterior uveitis is likely to hold maximum market share in the
global uveitis treatment market.
The global uveitis treatment market based
on drug class has been segregated into corticosteroid drugs,
anti-inflammatory drugs, immunosuppressive drugs, and others. The
corticosteroids drugs segment is anticipated to hold the largest share in the market
due to the rising preference in the treatment of uveitis.
The end-user segments of the market are
hospitals, specialty clinics, and others. The hospital's segment is expected to
hold the largest share of the market, as these are the primary locations where patients
receive treatment.
Regional Analysis
The market has been divided, by
region, into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa.
The Americas are anticipated to
hold the largest market share owing to the increasing prevalence of uveitis,
the presence of a well-established healthcare sector, and high R&D
expenditures. The uveitis treatment market in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada.
The European uveitis treatment
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The uveitis treatment market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. Due to the presence of a large patient
pool and expansion of healthcare facilities, the market in Asia-Pacific is
expected to be the fastest-growing. The uveitis treatment market in the Middle
East & Africa has been divided into the Middle East and Africa.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment